Figure S2. (A) Semi-quantification of CYGB overexpression Western blot results. CYGB expression in vector-transfected cells were set as 1. (B) Suppression of CYGB in HMEC does not affect cell proliferation. Representative images of AO/EB staining of MCF7 and MB231 cells transfected with CYGB or control plasmid. The cells were cultured on coverslips, stained with AO/EB and photographed under a fluorescence microscope. (TIF 1224 kb
Laser microdissection of pan-cytokeratin (AE1/AE3)-immunostained FFPE specimens. Figure S2. A-B Vali...
Figure S1 4EBP1 knockdown inhibits proliferation of MCF7 and T47D breast cancer cells. (a) Western b...
Table S1. Clinical data from patients for western blot assay (Fig. S1a). Table S2. Clinical data fro...
Figure S3. Representative images of AO/EB staining of MCF7 and MB231 cells transfected with CYGB or ...
Figure S5. Overexpression of CYGB in p53-null H1299 cells suppressed GLUT1 and HXK2 expression in p5...
Figure S1. CYGB expression and promoter methylation in breast cancer. (A) Analysis of CYGB mRNA expr...
Figure S4. Inverse association between CYGB and (A) GLUT1 and (B) HXK2 expression in breast cancer. ...
Figure S6. Ectopic HXK2 expression partially reversed CYGB’s effect on proliferation and apoptosis. ...
Figure S2 4EBP1 knockdown slows proliferation of SUM-229 and SUM-149 breast cancer cells. (a) Wester...
CREB3L1 protein expression in a panel of breast cancer cell lines. Cell lysates (50 μg protein/lane)...
Figure S1. Protein activity suppressed by inhibitors. Western blot quantification and short time poi...
Figure S2. CeRNET_CC promotes the stemness of MDA-MB-231 cells in vitro. (A and B) The infection eff...
Figure S3. (a) Representative western blot (left) and quantification (right) of three separate exper...
Figure S3. ErbbB2 and Mek downregulate ΔNp63α in detached breast epithelial cells. MCF10A and MCF-Er...
Graphs present the IC50 with the 95% confidence intervals for the seven tested cell lines obtained f...
Laser microdissection of pan-cytokeratin (AE1/AE3)-immunostained FFPE specimens. Figure S2. A-B Vali...
Figure S1 4EBP1 knockdown inhibits proliferation of MCF7 and T47D breast cancer cells. (a) Western b...
Table S1. Clinical data from patients for western blot assay (Fig. S1a). Table S2. Clinical data fro...
Figure S3. Representative images of AO/EB staining of MCF7 and MB231 cells transfected with CYGB or ...
Figure S5. Overexpression of CYGB in p53-null H1299 cells suppressed GLUT1 and HXK2 expression in p5...
Figure S1. CYGB expression and promoter methylation in breast cancer. (A) Analysis of CYGB mRNA expr...
Figure S4. Inverse association between CYGB and (A) GLUT1 and (B) HXK2 expression in breast cancer. ...
Figure S6. Ectopic HXK2 expression partially reversed CYGB’s effect on proliferation and apoptosis. ...
Figure S2 4EBP1 knockdown slows proliferation of SUM-229 and SUM-149 breast cancer cells. (a) Wester...
CREB3L1 protein expression in a panel of breast cancer cell lines. Cell lysates (50 μg protein/lane)...
Figure S1. Protein activity suppressed by inhibitors. Western blot quantification and short time poi...
Figure S2. CeRNET_CC promotes the stemness of MDA-MB-231 cells in vitro. (A and B) The infection eff...
Figure S3. (a) Representative western blot (left) and quantification (right) of three separate exper...
Figure S3. ErbbB2 and Mek downregulate ΔNp63α in detached breast epithelial cells. MCF10A and MCF-Er...
Graphs present the IC50 with the 95% confidence intervals for the seven tested cell lines obtained f...
Laser microdissection of pan-cytokeratin (AE1/AE3)-immunostained FFPE specimens. Figure S2. A-B Vali...
Figure S1 4EBP1 knockdown inhibits proliferation of MCF7 and T47D breast cancer cells. (a) Western b...
Table S1. Clinical data from patients for western blot assay (Fig. S1a). Table S2. Clinical data fro...